MarPipe aims to discover and further develop lead compounds with anticancer and anti-infective activity that has already been identified by the consortium from extremophilic marine microorganisms.

MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, Ku Leuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8 countries (I, N, UK, D, B, IRL, E, NL), including 3 from the non-academic sector. We will train 11 ESRs in the field of marine drug-discovery, providing these researchers with unique skills towards becoming experts in their research field and to advance their careers in academia or industry. This means that the research and training envisaged in MarPipe project will implement all aspects of the drug-discovery chain, from isolation of microbial species/strains to clinical trials, from discovery to production, in addition to non-technical aspects, such as legal and entrepreneurial issues.  

More information here